Back to Emerging Issues in Oncology - Updates from ASCO -Solid Tumors (2019)
Emerging Issues in Oncology - Updates from ASCO -Solid Tumors (2019)

Emerging Issues in Oncology - Updates from ASCO -Solid Tumors (2019)

HOPA is pleased to present the second of a five-webinar series, which will review key findings from clinical and translational research, and data presented at national oncology meetings.

This BCOP webinar will overview key abstracts presented at the American Society of Clinical Oncology 55th Annual Meeting in Chicago, IL May 31 through June 4, 2019.  This module will include practice advancing abstracts in sarcoma, breast, head and neck, non-small cell lung, prostate, bladder, and pancreatic cancers.  At the end of this presentation, the audience will be able to demonstrate application of emerging ASCO data to real world oncology patients.

Product Details

Speaker: Heidi D. Finnes, PharmD BCOP

Heidi D. Finnes, PharmD, BCOP is the Senior Manager Pharmacy Cancer Center Research at the Mayo Clinic Cancer Center in Rochester, MN.  Dr. Finnes obtained her Doctor of Pharmacy degree from Drake University, Des Moines, Iowa in 1998 and her Board Certification in Oncology Pharmacy in 2003. Dr. Finnes is the director of the Mayo Clinic Cancer Center Pharmacy Shared Resource and provides input on oncology clinical trials during protocol development, authors drug templates and offers recommendations for therapy and supportive care. She prepares investigational drug order sets for Epic/Beacon and completes electronic and face to face pharmacy consultations on hematology/oncology patients.  Dr. Finnes is the chair of the Alliance for Clinical Trials in Oncology Pharmacy Committee and is active on the Alliance Neuro-Oncology, Cancer Control and Chemoprevention and Experimental Therapeutics Committees.  She is a member of the Eastern Oncology Cooperative Group Pharmacy and Melanoma committees.  Her research interests include medication therapy management in hematology/oncology patients, pharmacology of experimental therapeutics, and treatment of melanoma.  She is also active in the Hematology Oncology Pharmacists Association (HOPA) and served as a HOPA board member at-large, liaison for BCOP committees, chair of the Program Committee and is the current chair of the Time to Talk Immuno-Oncology Task Force.

  • List Price: $70.00 USD
  • Member Price: $40.00 USD
Join and Save!
Log into see if you qualify for a lower price.
HOPA members save $30.00 USD or more!
Become a member